Orchid SRV: Cutting-edge Innovation to Prevent IV Dislodgement
By MedTech Outlook | Wednesday, January 09, 2019
Healthcare has undergone unprecedented changes in delivery system operations, especially the medical devices manufacturing companies that are disrupting the marketplace. Most of these companies are focusing on leveraging the technologies in manufacturing medical devices. In the past, it accidental dislodgement of IV catheters was a life-threatening situation. Linear Sciences Health is the developer of Orchid Safety Release Valve (OSRV) as a solution for medical tubing. When dislocations occur, providers normally address them with time-consuming IV restarts because there is no other way to respond to the dislocation of the catheter without a device like the Orchid SRV. Reducing accidental catheter dislodgement means mitigating the nursing time spent on IV restarts. When dislodgement of the catheter occurs, the entire IV setup need not be replaced. The fluid flow can thus be resumed simply by replacing the OSRV. Linear Health Sciences is a manufacturer of medical tubing products that develops cutting-edge, innovative technology to prevent unwanted disconnection of medical tubing from patients.
Linear Health Sciences has collaborated with Alliance Medical to procure the global patent rights for OSRV to prevent intravenous dislodgement of catheters. “This is an exciting milestone for our company. Partnering with a premier distribution group with expertise in launching innovative, new-to-market infusion products perfectly aligns with Linear Health's overall commercial strategy and goals for protecting every line, every time,” says Dan Clark, co-founder and president of Linear Health Sciences. Alliance Medical is the leading distributor of emerging medical technologies, and it represents OSRV product in the United States. IV catheter dislodgement is a pervasive experience in the U.S. hospitals. Up to 90 percent of patients in hospitals receive IV, and clinical studies demonstrate that an average of 15 percent of patients is dislodged. IV dislodgement may lead to interruptions in necessary treatments and greater stress and anxiety for patients.
Moreover, restarting a dislocated catheter can cost more than $30 each for staff and equipment. Almost all respondents in a 2017 survey of nurses and vascular access specialists disclosed that their institutions considered IV dislodgement a safety risk. A patented breakaway technology is used by the Orchid SRV to defend against unintended dislodgement. When a sudden pressure is applied, the SRV breaks and seals off both sides of the IV to protect the insertion site and prevent the loss of valuable drugs.
Alliance Medical is a national specialty sales and distribution company that has partnered with some of the world’s leading vascular access companies. The company was formed to offer manufacturers the entire U.S. coverage for new product launches. Linear Health Sciences is currently pursuing FDA clearance for the Orchid SRV and plans to launch it commercially in spring 2019.